Diffusion of Surgical Techniques in Early Stage Breast Cancer: Variables Related to Adoption and Implementation of Sentinel Lymph Node Biopsy

BackgroundUnderstanding how physicians acquire and adopt new technologies for cancer diagnosis and treatment is poorly understood, yet is critical to the dissemination of evidence-based practices. Sentinel lymph node biopsy (SLNB) has recently become a standard technique for axillary staging in early breast cancer and is an ideal platform for studying medical technology diffusion. We sought to describe the timing of SLNB adoption and patterns of surgeon interactions with the following educational sources: local university training program, surgical literature, national meetings/courses, national specialty centers, and other local surgeons.MethodsA cross-sectional survey that used semistructured interviews was used to assess timing of adoption, practice patterns, and learning sources for SLNB among surgical oncologists and general surgeons in a single metropolitan area.ResultsA total of 44 eligible surgeons were identified; 38 (86%) participated. All surgical oncologists (11 of 11) and most general surgeons (26 of 27) had implemented SLNB. Surgical oncologists were older (mean 51 vs. 48 years, P = .02) and had used SLNB longer (6.1 vs. 3.3 years, P = .01) than general surgeons. By use of social network diagrams, surgical oncologists and the university training program were shown to be key intermediaries between general surgeons and national specialty centers. Surgeons in group practice tended to use more learning sources than solo practitioners.ConclusionsSurgical oncologists and university-based surgeons play key educational roles in disseminating new cancer treatments and therefore have a professional responsibility to educate other community physicians to increase the use of the most current, evidence-based practices.

[1]  Kurt G. Davis,et al.  Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense. , 2002, American journal of surgery.

[2]  C. Teddlie,et al.  SAGE Handbook of Mixed Methods in Social & Behavioral Research , 2010 .

[3]  K. McMasters,et al.  Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. , 2005, American journal of surgery.

[4]  J. H. Frey,et al.  The Interview: From Structured Questions to Negotiated Text , 2000 .

[5]  Stanley Wasserman,et al.  Wasserman, Stanley, and Katherine Faust, Social Network Analysis: Methods and Applications. New York: Cambridge University Press, 1994. , 1994 .

[6]  C. Ko,et al.  Beyond the Clinical Trials: How Often Is Sentinel Lymph Node Dissection Performed for Breast Cancer? , 2004, Annals of Surgical Oncology.

[7]  E. McGlynn,et al.  The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[8]  A. Fagerlin,et al.  Surgeon perspectives about local therapy for breast carcinoma , 2005, Cancer.

[9]  A. Buzdar,et al.  How rapidly do oncologists respond to clinical trial data? , 2005, The oncologist.

[10]  F. Peintinger,et al.  Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.

[11]  J. Morse.  Qualitative data analysis (2nd ed): Mathew B. Miles and A. Michael Huberman. Thousand Oaks, CA: Sage Publications, 1994. Price: $65.00 hardback, $32.00 paperback. 238 pp , 1996 .

[12]  D. Stryer,et al.  Translating research into practice: the future ahead. , 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  A. Giuliano,et al.  Sentinel Node Skills Verification and Surgeon Performance: Data From a Multicenter Clinical Trial for Early-Stage Breast Cancer , 2005, Annals of surgery.

[14]  Stanley Wasserman,et al.  Social Network Analysis: Methods and Applications , 1994 .

[15]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[16]  E. White,et al.  Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma , 1999, Cancer.

[17]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[18]  J. Lofland,et al.  Analyzing Social Settings , 1971 .

[19]  A B Nattinger,et al.  Geographic variation in the use of breast-conserving treatment for breast cancer. , 1992, The New England journal of medicine.

[20]  Rebecca Ottesen,et al.  Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. , 2003, Journal of the National Cancer Institute.

[21]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[22]  S. Edge,et al.  Treatment of early-stage breast cancer. , 1999, Current problems in cancer.

[23]  Umberto Veronesi,et al.  Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .

[24]  Jeremy M. Grimshaw,et al.  Changing Provider Behavior: An Overview of Systematic Reviews of Interventions , 2001, Medical care.

[25]  E. Rogers.  Diffusion of Innovations , 1962 .

[26]  L. Clegg,et al.  Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Berwick.  Disseminating innovations in health care. , 2003, JAMA.

[28]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[29]  H. Cody,et al.  Redefining prognosis in node-negative breast cancer: Can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy? , 2004, Annals of Surgical Oncology.

[30]  K. McMasters,et al.  Defining the Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques , 2001, Annals of surgery.

[31]  D. Thomas,et al.  Change in the use of breast-conserving surgery in western Washington after the 1990 NIH Consensus Development Conference. , 1997, Archives of surgery.

[32]  P B Cerrito,et al.  Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  N. Denzin,et al.  Handbook of Qualitative Research , 1994 .

[34]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  S. Miller,et al.  Systematic Review: The Relationship Between Clinical Experience and Quality of Health Care , 2006 .

[36]  NIH consensus conference. Treatment of early-stage breast cancer. , 1991, JAMA.

[37]  B. Gusterson,et al.  Role of immunohistochemical detection of lymph-node metastases in management of breast cancer , 1999, The Lancet.

[38]  J. Gurwitz,et al.  Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[40]  L. Kohn,et al.  COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .

[41]  E. Feuer,et al.  Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.

[42]  J. Adamson.  Handbook of Mixed Methods in Social and Behavioural Research. Tashakkori A, Teddlie C (eds). Thousand Oaks: Sage, 2003, pp.768, £77.00 ISBN: 0-7619-2073-0. , 2004 .

[43]  Andreas Shamiyeh,et al.  Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.

[44]  L. Clegg,et al.  Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  M. Schijven,et al.  Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[46]  A. Lucci,et al.  National practice patterns of sentinel lymph node dissection for breast carcinoma. , 2001, Journal of the American College of Surgeons.

[47]  Stephen E. Jones.  Implications of the NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer , 1991 .

[48]  K. Mokbel,et al.  The sentinel node biopsy is a new standard of care for patients with early breast cancer. , 2004, International journal of fertility and women's medicine.